Health Catalyst Inc (NASDAQ:HCAT) currently has a daily average trading volume of 535.51K but it saw 2666185 shares traded in last market. With a market cap of 445.68M USD, the company’s current market price of $7.55 came rising about 37.77 while comparing to the previous closing price of $5.48. In past 52 weeks, the stock remained buoying in the range of price level as high as $13.53 and as low as $5.42. In the recent trading on the day, stock has struck highest price mark of $6.46 while lowest mark touched by it was $7.85.
Taking a look at 20-day trading activity of Health Catalyst Inc (HCAT) gives us an average price of $7.08, while its current price level is -44.20% below from 52-week high level whereas it is 39.30% above from lowest level seen by the stock during that period. Simple moving average of 50 days or SMA-50 of the stock’s closing price is $6.63 while that of 200 days or SMA-200 reads an average of $7.65. A closer look into the stock’s movement over the week reveals that its volatility is standing at 10.26% during that period while stretching the period over a month that decreases to 7.76%. It is also necessary to take a look into other indicators of a stock too, to get a better idea about its price movement. And in doing so, we find stock’s 14-day relative strength index (RSI) standing at 57.50 which implies that the stock is in neutral territory.
Evercore ISI upgraded its recommendation for the stock as a “Outperform” from “In-line” on January 03, 2024 while assigning a price target of $11. Barclays issued its recommendations for the stock as it initiated the price target for the stock is $14.
Over the week, HCAT’s stock price is moving 6.19% up while it is 28.84% when we observe its performance for the past one month. Year-to-date it is -18.47% down and over the past year, the stock is showing a downside performance of -41.70%.
The latest quarterly earnings report issued by the company reported quarterly earnings per share (EPS) of 0.03 beat the consensus estimate of -0.02 for the same. In next quarter, company is expected to be making quarterly sales of $80.07M as analysts are expecting the sales for current fiscal year at $307.76M and seeing the company making $343.51M in sales next year. Moreover, analysts are in estimates of $77.88M for current-quarter revenue.
Currently, Health Catalyst Inc’s total number of outstanding shares is 58.30M with 2.97% of that held by the insiders while 88.50% of its common stock has been owned by the institutions. Company’s return on investment (ROI) stands at -23.14% and return on equity (ROE) at -23.15%. It has a 15.60 of forward P/E ratio. Stock’s beta reads 1.37. Stock has a price to book (P/B) ratio of 1.27 while price to sale or P/S ratio amounts to 1.49. Its return on asset (ROA) is -12.22% on average.
